Study of skin related adverse effects of chemotherapy drugs and radiotherapy in cancer patients
Not Applicable
- Conditions
- Health Condition 1: L599- Disorder of the skin and subcutaneous tissue related to radiation, unspecified
- Registration Number
- CTRI/2023/08/056465
- Lead Sponsor
- -
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients receiving chemotherapy and radiotherapy irrespective of their age and sex.
Patients willing to participate.
Exclusion Criteria
Patient with mucocutaneous manifestation due to malignancy.
Known Prior primary dermatoses.
Drug reaction due to Non-Chemotherapeutic Drugs.
Mucocutaneous manifestation of Paraneoplastic syndromes.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the various mucocutaneous manifestations in patients with solid organ malignancy or haematological malignancy receiving chemotherapy and radiotherapy.Timepoint: 1 year 2 months
- Secondary Outcome Measures
Name Time Method â?¢To find out the frequency of mucocutaneous manifestation in patient receiving chemotherapy. <br/ ><br> <br/ ><br>â?¢To find out the frequency of mucocutaneous manifestation in patient receiving radiotherapy. <br/ ><br> <br/ ><br>â?¢To know the various pattern of mucocutaneous involvement in chemotherapy. <br/ ><br> <br/ ><br>â?¢To know the various pattern of mucocutaneous involvement in radiotherapy. <br/ ><br> <br/ ><br>â?¢To assess the severity of mucocutaneous involvement with the chemotherapeutic drugs. <br/ ><br>Timepoint: 1 year 2 months